Postherpetic Neuralgia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Global Postherpetic Neuralgia API Manufacturers, Marketed and Phase III Drugs Landscape Report 2018 ... - Business Wire (press release)



Global Postherpetic Neuralgia API Manufacturers, Marketed and Phase III Drugs Landscape Report 2018 ... 
Business Wire (press release)
Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018' report provides comprehensive insights about marketed and Phase III products for Postherpetic Neuralgia . The report includes information of marketed ...

and more » 


Postherpetic Neuralgia Market Pipeline Therapeutics, Products by ... - The Financial



Postherpetic Neuralgia Market Pipeline Therapeutics, Products by ... 
The Financial
Postherpetic Neuralgia Market Pipeline therapeutics 2018 presents an in-depth assessment of the pipeline (under development) therapeutics scenario and growth prospects across Postherpetic Neuralgia Market development. The report additionally provides ...

and more » 


Postherpetic Neuralgia Market Epidemiology, Drug Description, Mechanism of Action, Regulatory Milestones and ... - Investor Opinion



Postherpetic Neuralgia Market Epidemiology, Drug Description, Mechanism of Action, Regulatory Milestones and ... 
Investor Opinion
Postherpetic Neuralgia Market Epidemiology and Market Forecast 2027, in-depth analysis of the Postherpetic Neuralgia Industry epidemiology and market outlook for the 7MM. The report provides the overview of the Postherpetic Neuralgia Market by the ...

and more » 


New Shingles Vaccine Found to Be More Effective | Everyday Health - Everyday Health, Inc. (blog)



Everyday Health, Inc. (blog)
 
New Shingles Vaccine Found to Be More Effective | Everyday Health 
Everyday Health, Inc. (blog)
A newly available shingles vaccine is more effective at preventing the painful condition, a development that may convince more people to get vaccinated.
New shingles vaccination keeps the pox from striking back in older ... Calgary Herald

all 2 news articles » 


Should Gabapentin Be a Controlled Substance? - Pain News Network



Pain News Network
 
Should Gabapentin Be a Controlled Substance? 
Pain News Network
The U.S. Drug Enforcement Administration should consider scheduling gabapentin (Neurontin) as a controlled substance, according to researchers who studied the recreational use of the drug in Kentucky. Gabapentin is a nerve medication approved by the ...

 


Key events next week - healthcare - Seeking Alpha



Key events next week - healthcare 
Seeking Alpha
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction Winter Meeting, Austin, TX (five days). GTx (NASDAQ:GTXI): Phase 2 enobosarm data in women with stress urinary incontinence. Wednesday (2/28): Valeant Pharmaceuticals (NYSE:VRX ...

 


What Rheumatologists Need to Know in the Era of Herpes Zoster ... - Healio



What Rheumatologists Need to Know in the Era of Herpes Zoster ... 
Healio
Healio Rheumatology | Herpes zoster has become a topic of increasing interest and importance to our profession over the past number of years for several reasons, the most pressing of which is that our patients are 1.5 to 2 times more likely to develop ...

and more » 


Is Abuse of Nerve Pain Drugs Increasing? | Bloomberg Law - Bloomberg BNA



Is Abuse of Nerve Pain Drugs Increasing? | Bloomberg Law 
Bloomberg BNA
The FDA wants to make sure doctors don't respond to the opioid epidemic by over-prescribing another class of addictive drugs?nerve pain drugs.

and more » 


Shingrix: Is the Hype Justified? - Medscape



Medscape
 
Shingrix: Is the Hype Justified? 
Medscape
Hi. My name is Paul Offit. I'm talking to you from the Vaccine Education Center at Children's Hospital of Philadelphia. I want to talk about a newly licensed and recommended shingles vaccine. Shingles, as you know, is a reactivation of an original ...

 


U of T expert on the importance of getting shingles vaccine if you're 50 and older - News@UofT



News@UofT
 
U of T expert on the importance of getting shingles vaccine if you're 50 and older 
News@UofT
About 13 per cent of people with shingles develop a chronic pain syndrome called postherpetic neuralgia, with significant pain that can be difficult to control. The pain is often described as burning or stabbing pain, sometimes with an altered ...